Long-term Study of CS-3150 as Monotherapy or in Combination With Other Antihypertensive Drug in Japanese Patients With Essential Hypertension

NCT02722265 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

368

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: CS-3150

Sponsor

Daiichi Sankyo Co., Ltd.